Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nalla Usha Kumari

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nanomedicine (London, England)|May 3, 2024
Tailoring micellar nanocarriers for pemetrexed in breast cancer: design, fabrication and <i>in vitro</i> evaluationNalla Usha Kumari, Padakanti Sandeep Chary, Ekta Pardhi, et al.
Therapeutic Delivery|February 20, 2024
Exploring contemporary breakthroughs in utilizing vesicular nanocarriers for breast cancer therapyNalla Usha Kumari, Ekta Pardhi, Padakanti Sandeep Chary, et al.
Drug Discovery Today|April 8, 2026
Addressing delivery and resistance issues of CDK4/6 inhibitors as cancer therapeuticsKshitiz Luthra, Nalla Usha Kumari, Sri Pada Datta Chigurupati, et al.
AAPS Pharmscitech|December 14, 2023
Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast CancerYirivinti Hayagreeva Dinakar, Naveen Rajana, Nalla Usha Kumari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2025
Pre-programming the protein corona: From avoidance to endogenous targetingNalla Usha Kumari, Sri Pada Datta Chigurupati, Naveen Rajana, et al.
ACS Applied Bio Materials|July 28, 2025
Translational Potential of Surface Engineered Extracellular Vesicles as Theranostic Nanocarriers in Cancer Management: Recent Developments from Bench to BedsideRavindra Vasave, Rohit Bhawale, Omar Khan, et al.
ACS Applied Bio Materials|April 27, 2026
Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual PropertyAayushi Pandey, Rohit Bhawale, Ravindra Vasave, et al.
International Journal of Biological Macromolecules|January 26, 2025
Fabrication and characterization of teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles for the management of triple negative breast cancerNaveen Rajana, Lakshmi Tulasi Naraharisetti, Nalla Usha Kumari, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nanomedicine (London, England)|May 3, 2024
Tailoring micellar nanocarriers for pemetrexed in breast cancer: design, fabrication and <i>in vitro</i> evaluationNalla Usha Kumari, Padakanti Sandeep Chary, Ekta Pardhi, et al.
Therapeutic Delivery|February 20, 2024
Exploring contemporary breakthroughs in utilizing vesicular nanocarriers for breast cancer therapyNalla Usha Kumari, Ekta Pardhi, Padakanti Sandeep Chary, et al.
Drug Discovery Today|April 8, 2026
Addressing delivery and resistance issues of CDK4/6 inhibitors as cancer therapeuticsKshitiz Luthra, Nalla Usha Kumari, Sri Pada Datta Chigurupati, et al.
AAPS Pharmscitech|December 14, 2023
Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast CancerYirivinti Hayagreeva Dinakar, Naveen Rajana, Nalla Usha Kumari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2025
Pre-programming the protein corona: From avoidance to endogenous targetingNalla Usha Kumari, Sri Pada Datta Chigurupati, Naveen Rajana, et al.
ACS Applied Bio Materials|July 28, 2025
Translational Potential of Surface Engineered Extracellular Vesicles as Theranostic Nanocarriers in Cancer Management: Recent Developments from Bench to BedsideRavindra Vasave, Rohit Bhawale, Omar Khan, et al.
ACS Applied Bio Materials|April 27, 2026
Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual PropertyAayushi Pandey, Rohit Bhawale, Ravindra Vasave, et al.
International Journal of Biological Macromolecules|January 26, 2025
Fabrication and characterization of teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles for the management of triple negative breast cancerNaveen Rajana, Lakshmi Tulasi Naraharisetti, Nalla Usha Kumari, et al.
Pageof 1